Gatta, N.G.; Parente, A.; Guida, F.; Maione, S.; Gentile, V.
Neuronutraceuticals Modulate Lipopolysaccharide- or Amyloid-β 1-42 Peptide-Induced Transglutaminase 2 Overexpression as a Marker of Neuroinflammation in Mouse Microglial Cells. Appl. Sci. 2021, 11, 5718.
https://doi.org/10.3390/app11125718
AMA Style
Gatta NG, Parente A, Guida F, Maione S, Gentile V.
Neuronutraceuticals Modulate Lipopolysaccharide- or Amyloid-β 1-42 Peptide-Induced Transglutaminase 2 Overexpression as a Marker of Neuroinflammation in Mouse Microglial Cells. Applied Sciences. 2021; 11(12):5718.
https://doi.org/10.3390/app11125718
Chicago/Turabian Style
Gatta, Nicola Gaetano, Andrea Parente, Francesca Guida, Sabatino Maione, and Vittorio Gentile.
2021. "Neuronutraceuticals Modulate Lipopolysaccharide- or Amyloid-β 1-42 Peptide-Induced Transglutaminase 2 Overexpression as a Marker of Neuroinflammation in Mouse Microglial Cells" Applied Sciences 11, no. 12: 5718.
https://doi.org/10.3390/app11125718
APA Style
Gatta, N. G., Parente, A., Guida, F., Maione, S., & Gentile, V.
(2021). Neuronutraceuticals Modulate Lipopolysaccharide- or Amyloid-β 1-42 Peptide-Induced Transglutaminase 2 Overexpression as a Marker of Neuroinflammation in Mouse Microglial Cells. Applied Sciences, 11(12), 5718.
https://doi.org/10.3390/app11125718